Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1907607 Target Snapshot

GABA-A receptor; anion channel · PROTEIN COMPLEX GROUP · Rattus norvegicus

3,354Compounds
548Assays
28Approved Drugs
3,910.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt O09028. Use UniProt O09028 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O09028 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats GABA-A receptor; anion channel as ChEMBL target CHEMBL1907607, mapped to UniProt O09028. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
GABA-A receptor; anion channel
PROTEIN COMPLEX GROUP · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL1907607
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
O09028
Gamma-aminobutyric acid receptor subunit pi
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether GABA-A receptor; anion channel is the right protein anchor across sources, using UniProt O09028 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGamma-aminobutyric acid receptor subunit pi
UniProt AccessionO09028
Component TypeProtein
Sequence Length440 aa

Gamma-aminobutyric acid receptor subunit pi

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as GABA-A receptor; anion channel, mapped to UniProt O09028. ChEMBL maps the protein component as Gamma-aminobutyric acid receptor subunit pi. Sequence length is 440 aa.

Mapped IDO09028
Review nameGABA-A receptor; anion channel
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

28
Approved
5
Phase III
15
Phase II
4
Phase I
Assay Mix

Activity Type Distribution

IC502,364.0
KI1,497.0
EC5016.0
KD33.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL380906 10.32 Ki 0.048 Preclinical
CHEMBL3144615 10.3 Ki 0.05 Preclinical
CHEMBL3144841 10.05 Ki 0.09 Preclinical
CHEMBL54338 10.0 Ki 0.1 Preclinical
CHEMBL80436 10.0 IC50 0.1 Preclinical
CHEMBL3144739 10.0 IC50 0.1 Preclinical
CHEMBL413744 9.96 IC50 0.11 Preclinical
CHEMBL3144609 9.92 Ki 0.12 Preclinical
CHEMBL19732 9.89 Ki 0.13 Preclinical
CHEMBL19732 9.89 IC50 0.13 Preclinical
Distribution

pChEMBL Value Distribution

322
5.0
267
5.5
312
6.0
368
6.5
396
7.0
301
7.5
313
8.0
206
8.5
158
9.0
31
9.5
pChEMBL
Approved Drugs

Approved Drugs

ZURANOLONE
CHEMBL4105630
Approved 2023
GANAXOLONE
CHEMBL1568698
Approved 2022
BREXANOLONE
CHEMBL207538
Approved 2019
ZOLPIDEM
CHEMBL911
Approved 1992
FLUMAZENIL
CHEMBL407
Approved 1991
CLARITHROMYCIN
CHEMBL1741
Approved 1991
CIPROFLOXACIN
CHEMBL8
Approved 1987
NORFLOXACIN
CHEMBL9
Approved 1986
MIDAZOLAM
CHEMBL655
Approved 1985
ALPRAZOLAM
CHEMBL661
Approved 1981
TRIAZOLAM
CHEMBL646
Approved 1978
BACLOFEN
CHEMBL701
Approved 1977
CLONAZEPAM
CHEMBL452
Approved 1975
DIAZEPAM
CHEMBL12
Approved 1963
CHLORDIAZEPOXIDE
CHEMBL451
Approved 1960
Assay Landscape

Assay Landscape

548
Total Assays
2,293
Tested Compounds
3
Assay Types
Binding — 510 assays, 2,293 compounds
BAO Format Assays Compounds Avg pChEMBL
protein complex format 149 316 7.1
cell membrane format 126 781 7.0
assay format 118 568 6.7
tissue-based format 106 592 6.9
subcellular format 6 36 6.1
organism-based format 5 0
Functional — 35 assays, 71 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 17 67 7.5
organism-based format 9 0
cell-based format 6 2 4.8
tissue-based format 2 0
cell membrane format 1 2 5.5
Toxicity — 3 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 3 1 5.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine